Compare Lustrum:KAINOS Laboratories,Inc.:4556

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index KAINOS Laboratories,Inc. Go to web site 4556 Medicals 東証スタンダード March 1, 2000 1995.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

KAINOS Laboratories,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAINOS Laboratories,Inc. Balance Sheet 2024年3月期 KAINOS Laboratories,Inc. Balance Sheet 2023年3月期 KAINOS Laboratories,Inc. Balance Sheet 2022年3月期 KAINOS Laboratories,Inc. Balance Sheet 2021年3月期 KAINOS Laboratories,Inc. Balance Sheet 2020年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Cash and Cash Equivalents
(Percent)
3,174up
(36.9%)down
3,020up
(37.2%)up
2,677up
(35.4%)up
2,244up
(32.2%)up
1,964
(29.1%)
Other Current AssetsHelp
(Percent)
2,520up
(29.3%)up
2,199up
(27.1%)up
2,013up
(26.6%)up
1,814down
(26.1%)down
1,842
(27.3%)
Tangible Fixed AssetsHelp
(Percent)
2,506down
(29.2%)down
2,547up
(31.4%)down
2,535up
(33.5%)down
2,532down
(36.4%)down
2,539
(37.7%)
Intangible Fixed AssetHelp
(Percent)
17down
(0.2%)down
31down
(0.4%)down
57down
(0.8%)down
98down
(1.4%)down
138
(2.0%)
Investments and OthersHelp
(Percent)
374up
(4.4%)up
319up
(3.9%)up
289up
(3.8%)down
275up
(4.0%)up
261
(3.9%)
Total AssetsHelp
(Percent)
8,591
(100%)
8,116
(100%)
7,572
(100%)
6,962
(100%)
6,745
(100%)
Total Current LiabilitiesHelp
(Percent)
2,017up
(23.5%)down
1,977up
(24.4%)up
1,827down
(24.1%)down
1,930up
(27.7%)down
1,874
(27.8%)
Total Long-term LiabilitiesHelp
(Percent)
307down
(3.6%)down
469down
(5.8%)down
544up
(7.2%)up
373down
(5.4%)down
489
(7.2%)
Shareholder's EquityHelp
(Percent)
6,266up
(72.9%)up
5,670up
(69.9%)up
5,200up
(68.7%)up
4,660up
(66.9%)up
4,381
(65.0%)
Total LiabilitiesHelp
(Percent)
8,591
(100%)
8,116
(100%)
7,572
(100%)
6,962
(100%)
6,745
(100%)

KAINOS Laboratories,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAINOS Laboratories,Inc. Profit and Loss Account 2024年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2023年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2022年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2021年3月期 KAINOS Laboratories,Inc. Profit and Loss Account 2020年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Amount of Sales
(Percent)
5,056
(100%)
4,923
(100%)
4,615
(100%)
4,258
(100%)
4,609
(100%)
Total Sales
(Percent)
5,056
(100%)
4,923
(100%)
4,615
(100%)
4,258
(100%)
4,609
(100%)
Cost of SalesHelp
(Percent)
2,505up
(49.5%)up
2,410up
(48.9%)up
2,207up
(47.8%)up
1,947down
(45.7%)down
2,230
(48.4%)
Other Costs and RevenueHelp 1,914down
(37.8%)down
1,945up
(39.5%)down
1,895up
(41.1%)down
1,894down
(44.5%)up
1,981
(43.0%)
Total CostsHelp 4,418 4,355 4,102 3,840 4,211
Net RevenueHelp 2,552up
(50.5%)down
2,513up
(51.1%)down
2,407up
(52.2%)down
2,311down
(54.3%)up
2,379
(51.6%)
Earnings Before TaxHelp 930up
(18.4%)up
845up
(17.2%)up
767up
(16.6%)up
613up
(14.4%)up
599
(13.0%)
Net IncomeHelp 638up
(12.6%)up
568up
(11.5%)up
512up
(11.1%)up
417up
(9.8%)up
399
(8.6%)
当期純利益 638 568 512 417 399

KAINOS Laboratories,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

KAINOS Laboratories,Inc. Cash Flow Statement 2024年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2023年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2022年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2021年3月期 KAINOS Laboratories,Inc. Cash Flow Statement 2020年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
431down
(100.0%)down
545down
(100.0%)up
604up
(99.8%)down
591down
(100.0%)up
678
(63.7%)
Investing Cash Flow(ICF)Help
(Percent)
-73down
(-16.9%)down
-10up
(-1.9%)up
-141down
(-23.3%)down
-117down
(-19.8%)down
-52
(-4.9%)
Financing Cash FlowHelp
(Percent)
-204down
(-47.3%)down
-191down
(-35.1%)down
-31up
(-5.2%)up
-195down
(-32.9%)down
386
(36.3%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0down
(0.0%)up
0down
(0.0%)down
1up
(0.2%)up
0up
(0.0%)up
-0
(0.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn 154down
(35.8%)down
343down
(63.0%)down
433up
(71.5%)up
280down
(47.3%)down
1,011
(95.1%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

KAINOS Laboratories,Inc.

Company where related level is highHelp

Kubota Pharmaceutical Holdings Co.,Ltd.
KAINOS Laboratories,Inc.
Nippon Shinyaku Co.,Ltd.
K Pharma,Inc.
SAWAI GROUP HOLDINGS Co., Ltd.
Noile-Immune Biotech Inc.
Fuji Pharma Co.,Ltd.
KYORIN Pharmaceutical Co., Ltd.
Tsubota Laboratory Incorporated
AnGes,Inc.